Search

everythinglearnresearchcommunity

for

Search:↓

Wedelia trilobata flower extract could be a valuable ingredient for skin care products due to its antioxidant, antimicrobial, and anti-inflammatory properties.

Transcutol-containing vesicles improve minoxidil's skin penetration and hair growth promotion.

The HtrA1L364P mutation causes brain dysfunction and blood vessel damage.

Squalene-based carriers improve delivery of a treatment to hair follicles for alopecia areata.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Newly made nicotinamide compounds could potentially treat cancer.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

4-O-methylhonokiol from Magnolia Officinalis may promote hair growth by interfering with TGF-β1 effects in skin cells.

A new compound from Royoporus badius activates immune cells and induces inflammatory responses.

Ultrasound helps efficiently extract beneficial compounds from maidenhairtree for potential medicinal use.

Minoxidil in distearyldimethylammonium chloride vesicles significantly promotes hair growth, while minoxidil in microparticles or poloxamer solutions doesn't.

IPM enhances skin penetration of hydrophilic drugs.

CG2001 is safe and well-tolerated for treating hair loss in men.

Minoxidil mixed with β-cyclodextrin improves solubility and gradual release.

Calotropis gigantea and Tridax procumbens extracts reduce inflammation more effectively than low-dose Ibuprofen.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

TPA is about 50 times more effective at promoting tumors than MZ.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

Mutations at Val-889 and Arg-752 disrupt key interactions in the androgen receptor, affecting its function.

Treatments improved hair surface and scale structure but didn't increase certain bonds in the hair cortex.